The CU Healthcare Innovation Fund announced today that it has secured its maximum targeted committed capital of $50 million. The fund is affiliated with and located at the University of Colorado Anschutz Medical Campus near Denver.

Kelsea Pieters | July 07, 2020

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus today announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of 450,000 DNA samples and corresponding health records from de-identified, consented patient participants in the expansive UCHealth system. The Regeneron Genetics Center (RGC), a wholly owned subsidiary of Regeneron, has entered into the collaboration with CCPM and will sequence these samples, producing genomic data that can be used to facilitate translational medical research and ultimately enable physicians to make better decisions for their patients. 

Kelsea Pieters | May 11, 2020

Researchers at the University of Colorado Anschutz Medical Campus have found that interest in abortion care among advance practice clinicians (APCs) in Colorado is substantial, though barriers must be addressed in order to increase access with APCs (nurse practitioners, nurse midwives, physician’s assistants).

Kelsea Pieters | April 23, 2020

Assessing adverse childhood experiences and current anxiety and depression symptoms may help ease cognitive distress in women who have undergone a surgical menopause for cancer risk-reduction, or RRSO, according to a new study published in Menopause.

Kelsea Pieters | March 26, 2020

Michelle Barron, MD, professor of medicine and an infectious diseases expert, responds to questions about COVID-19. She addresses what's myth and what's fact, how it's spread, how we can contain it and when to see a doctor. 

Kelsea Pieters | March 10, 2020

Knowing the amount of opioids taken following cesarean section surgery and before discharge can inform individualized prescriptions and cut down on unnecessary, leftover pills that could be used for non-medical purposes, according to a new study from the University of Colorado Anschutz Medical Campus.

Kelsea Pieters | March 09, 2020